A randomized placebo controlled double blind crossover study of pioglitazone on left ventricular diastolic function in type 2 diabetes

    International journal of cardiology, Volume 167, Issue 4, 2013, Pages 1329-1332.

    Cited by: 13|Bibtex|Views0|Links
    WOS
    Keywords:
    diabetesdiastolic functionleft ventriclethiazolidinediones

    Abstract:

    Thiazolidinediones (TZDs), such as pioglitazone, are widely used to treat type 2 diabetes but there is evidence that their use is associated with an increased risk of heart failure. We compared the effect of pioglitazone vs. placebo on left ventricular (LV) diastolic and systolic function in people with type 2 diabetes.24 male or female p...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments